Skip to Content

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

Workouts in the Park? Crime Fears Keep Some Away

Parks can be good for your health, but fear of crime stops some people from using them, a new study finds. Previous research has shown that urban green spaces can lower stress levels, weight and heart disease risk, and that living near a park is linked to fewer days of anxiety and depression. This new study found that New York City residents are more...

Posted 3 days ago in New Drug Approvals

FDA Approves Hulio (adalimumab-fkjp), a Biosimilar to Humira

HERTFORDSHIRE, England and PITTSBURGH and TOKYO, July 9, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Hulio® (adalimumab-fkjp), a biosimilar to AbbVie's Humira® (adalimumab),...

Posted 3 days ago in New Drug Approvals

FDA Approves Upneeq (oxymetazoline hydrochloride ophthalmic solution) for Acquired Blepharoptosis (Droopy Eyelid) in Adults

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%, formerly known as RVL-1201, its novel treatment for acquired blepharoptosis,...

Posted 3 days ago in News for Health Professionals

Spectrum of Neurological Disorders Linked to SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a spectrum of neurological disorders, according to a study published online July 8 in Brain. Ross W. Paterson, Ph.D., from the University College London Queen Square Institute of Neurology, and colleagues collected detailed clinical and paraclinical data from...

Posted 2 days ago in Medical

Most Survivors of Severe COVID-19 Report Symptoms Many Weeks After 'Recovery'

Even a month after hospital discharge and "recovery," a majority of patients who had survived severe COVID-19 were still dealing with fatigue, shortness of breath and other symptoms, Italian research shows. The study tracked outcomes for 143 hospitalized patients treated in April in Rome, at the height of the Italian COVID-19 pandemic. They'd spent...

Posted 2 days ago in Medical

Cold War Antiseptic May Be Valuable Germ Fighter

A nontoxic antiseptic developed in the former Soviet Union may be a valuable weapon for fighting common infections, British researchers say. The drug, miramistin, was developed for the Soviet Space Program. While little known in the West, it blocks or kills flu, human papillomaviruses (HPV), coronaviruses, adenoviruses and HIV, according to University...

Posted 2 days ago in Medical

AHA News: More People Are Dying During the Pandemic – and Not Just From COVID-19

More people in the United States are dying during the COVID-19 pandemic, but not just because of the coronavirus. One reason, experts say, is people with other ailments may not be seeking help. That conclusion is emerging from new research showing deaths are increasing from causes such as heart disease, stroke and diabetes – while emergency room...

Posted 2 days ago in Medical

Antiviral Drugs Tied to Heart Issue in COVID-19 Patients

Older, critically ill COVID-19 patients who are given a combination of two common antiretroviral drugs can experience a drastic slowing of their heart rate, French researchers report. In their study of 41 patients treated with lopinavir and ritonavir twice daily for 10 days, 22% developed a slow heart rate condition called bradycardia. When the drugs...

Posted 2 days ago in Medical

U.S. Sees Another Record-Breaking Day of New Coronavirus Cases

States across America reported nearly 60,000 new coronavirus cases on Thursday, setting yet another daily record as the pandemic tightens its grip on a country struggling to reopen. The surge has been largely fueled by states in the South and the West that eased their lockdowns early, The New York Times reported. Single-day case records were set in...

Posted 2 days ago in Medical

Terrifying Delirium Can Strike Hospitalized COVID-19 Patients

Intense breathing problems may be the most widely reported feature of COVID-19, but new research warns that coronavirus can also take aim at the brain. Infection can trigger serious nerve damage, stroke, inflammation and even wild bouts of delirium. In fact, a bizarre array of delusions plagued nearly a quarter of the 43 British COVID patients whose...

Read more news...

Recently added consumer and prescribing information: Inqovi, Rukobia, Qwo, Gimoti, Dojolvi, Mycapssa, Fintepla, Uplizna, Oriahnn, Zepzelca

Posted in Blog

Feeling the heat? Maybe your medication is to blame.

With the weather heating up across the U.S. it seems good timing that most states are easing their lockdown restrictions. Escaping into the sun is something we are all looking forward to, especially after a winter of confinement at home. But did you know that heat-related deaths are one of the deadliest weather-related outcomes in […]

Posted in Blog

Vitamin C: Time to take this supplement seriously?

Vitamin C has always been a controversial supplement. To some, it belongs firmly in the alternative medicine basket, with apparently no substantial evidence to support its use. To others, it holds promise, particularly if you are talking about certain groups of people who are likely to be low in vitamin C. Because we NEED vitamin […]

Posted in Blog

Medical Advances Amidst COVID-19 Chaos

Undeniably, we are in unprecedented times. COVID-19 is a serious and fatal disease for some and globally it has, and will continue to have, wide-reaching implications, medically, socially, and financially for some time. But medical advances will be significant. Although we have learned a lot about the new coronavirus already, there is still a lot […]

See more blog posts or follow us on twitter.